The development of Cenforce 200 mg did not exactly "stop," but rather it is part of a range of Sildenafil Citrate-based medications manufactured and sold primarily for the treatment of erectile dysfunction (ED). Cenforce is a brand name for a generic version of Sildenafil, which was originally developed by the pharmaceutical company Pfizer under the brand name Viagra in the late 1990s.
Sildenafil, the active ingredient in Cenforce 200 mg was approved by the FDA in 1998 for the treatment of erectile dysfunction. Cenforce 200 mg was developed by the pharmaceutical company Centurion Laboratories as a more affordable alternative to Viagra and other branded Sildenafil medications.
The development of Cenforce 200 mg, and other doses like 100 mg or 50 mg, has continued in parallel with the growing market for generic versions of Sildenafil. Generic drugs like Cenforce have played a key role in making ED medications more accessible and affordable since the original patent for Viagra expired in 2020.
Thus, rather than a specific end to its development, the availability of Cenforce 200 mg reflects ongoing production and distribution in the market. It continues to be available as part of the broad range of Sildenafil-based treatments, though its development likely hasn't been the subject of major changes since its initial release.